BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2002
View Archived Issues
GSK discusses significant growth opportunities for the future at healthcare conference
Read More
Paladin and Pharmacia sign Canadian distribution agreement
Read More
AHP highlights next wave of products at investor conference
Read More
Anticonvulsants composed of valproic acid and carbonic anhydrase inhibitors
Read More
T-bet: an attractive target for antiasthmatic and possibly other drugs
Read More
SignalGene's antiangiogenesis drug candidate enters preclinical testing
Read More
Advair and Flovent Diskus recommended for approval by FDA committee
Read More
PARP inhibitor exerts significant antiinflammatory effects in a number of murine models
Read More
MCA gives green light to phase II trial of PTI-801
Read More
Immune Network collaborates with AIDS researcher at University of British Columbia
Read More
Modified-release NBI-34060 successfully completes phase II trial
Read More
Triangle updates its drug development portfolio
Read More
Health Canada clears Cytovax to initiate phase I trial of Cytovaxine
Read More
Survival data announced from phase II trial of GD-0039 in metastatic renal cancer
Read More
Eisai and Neurogenetics extend Alzheimer's disease agreement
Read More
IDM and Sanofi-Synthelabo begin cancer immunotherapy collaboration
Read More
Novel antibody therapeutic products to be codeveloped by Medarex and Zycos
Read More
Benzofuran and benzothiophene derivatives that inhibit 17alpha-hydroxylase/C17-20 lyase
Read More
Dual TxA2 and PGD2 antagonists described by scientists at Shionogi
Read More
Vitamin D analogues synthesized at Wisconsin Alumni Research Foundation
Read More
Dermabond product labeling changed to include protection against common microbes
Read More
Nippon Shinyaku reports series of heterocyclic compounds useful in cardiovascular diseases
Read More
Isoquinoline derivatives that selectively inhibit protein kinase B disclosed
Read More
Kosan researchers design epothilone derivatives with antitumor activity
Read More